Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unresectable Hepatocellular Carcinoma (HCC)”

660 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 660 results

Early research (Phase 1)Study completedNCT00486356
What this trial is testing

Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more
University of Nebraska 46
Not applicableActive Not RecruitingNCT05433701
What this trial is testing

Stereotactic Body Radiotherapy Versus Radiofrequency Ablation for Unresectable, Small (≤ 3 cm) HCC

Who this might be right for
Hepatocellular Carcinoma
Jonggi Choi 178
Testing effectiveness (Phase 2)Study completedNCT00639509
What this trial is testing

IMC-A12 in Treating Patients With Advanced Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT00040898
What this trial is testing

Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating Patients With Liver Cancer That Cannot Be Surgically Removed

Who this might be right for
Liver Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07157306
What this trial is testing

Gecacitinib Combined With Donafenib and PD-1 Inhibitor as Immune Rechallenge Therapy for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 35
Early research (Phase 1)Study completedNCT00537121
What this trial is testing

Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer

Who this might be right for
Esophageal CancerGastric CancerLiver Cancer
Roswell Park Cancer Institute 23
Not applicableUnknownNCT04523467
What this trial is testing

Anti-angiogenic Targeted Drugs Plus Rg3 to Improve the Efficacy of TACE for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 320
Early research (Phase 1)Study completedNCT00003548
What this trial is testing

Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity

Who this might be right for
Cancer
NYU Langone Health 20
Testing effectiveness (Phase 2)Looking for participantsNCT07291076
What this trial is testing

Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)

Who this might be right for
Hepatocellular Carcinoma (HCC)
Bristol-Myers Squibb 129
Large-scale testing (Phase 3)Looking for participantsNCT05557838
What this trial is testing

Study of Durvalumab Plus Tremelimumab as First-line Treatment in Chinese Patients With Unresectable Hepatocellular Carinoma

Who this might be right for
Hepatocellular Carcinoma
AstraZeneca 210
Large-scale testing (Phase 3)Study completedNCT00870558
What this trial is testing

Iodine I 131 Ethiodized Oil in Preventing Recurrent Cancer in Patients Who Have Undergone Treatment for Liver Cancer

Who this might be right for
Liver Cancer
Hospices Civils de Lyon 120
Testing effectiveness (Phase 2)UnknownNCT05134532
What this trial is testing

Regorafenib After Progression on Atezolizumab Plus Bevacizumab in Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
CHA University 40
Early research (Phase 1)Study completedNCT04676633
What this trial is testing

Safety, Tolerability, PK, Anti-Tumor Activity of STP705 in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard Therapy

Who this might be right for
Hepatocellular CarcinomaLiver MetastasesCholangiocarcinoma
Sirnaomics 5
Testing effectiveness (Phase 2)UnknownNCT00054951
What this trial is testing

Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads

Who this might be right for
Hepatocellular Carcinoma
FeRx 30
Not applicableStudy completedNCT01349075
What this trial is testing

TheraSphere for the Treatment of Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 474
Large-scale testing (Phase 3)UnknownNCT05263219
What this trial is testing

DEB-TACE+HAIC vs. HAIC for Large HCC

Who this might be right for
Unresectable Hepatocellular Carcinoma
Second Affiliated Hospital of Guangzhou Medical University 230
Early research (Phase 1)UnknownNCT03652467
What this trial is testing

The Safety and Efficacy of Deferoxamine for Treating Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Jinan Military General Hospital 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT04175912
What this trial is testing

Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver

Who this might be right for
Metastatic CholangiocarcinomaMetastatic Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v8+12 more
National Cancer Institute (NCI) 40
Large-scale testing (Phase 3)Study completedNCT00617981
What this trial is testing

Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Imunon 701
Load More Results